Cargando…

Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia

Detalles Bibliográficos
Autor principal:	Schuetz, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068823/ https://www.ncbi.nlm.nih.gov/pubmed/31800293 http://dx.doi.org/10.1164/rccm.201910-1970LE

Ejemplares similares

EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
por: ROY, ARCHANA, et al.
Publicado: (2021)

Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens
por: Fabre, Valeria, et al.
Publicado: (2020)

Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
por: Schuetz, Philipp, et al.
Publicado: (2011)

The role of lung ultrasound in procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia
por: Ammar, Mona A., et al.
Publicado: (2022)

Dexamethasone in community-acquired pneumonia
por: Lee, Nelson, et al.
Publicado: (2011)

Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study
por: Guillot, Pauline, et al.
Publicado: (2023)

Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study
por: Wang, Qiushi, et al.
Publicado: (2019)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Aetiological agents of community acquired pneumonia
por: Karabay, Oguz, et al.
Publicado: (2012)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia
por: Gilbert, David, et al.
Publicado: (2016)

2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Huttner, Benedikt, et al.
Publicado: (2020)

Procalcitonin-guided diagnosis and antibiotic stewardship revisited
por: Sager, Ramon, et al.
Publicado: (2017)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

Procalcitonin-guided antibiotic usage - addressing heterogeneity in meta-analysis
por: Birajdar, Amit Ravindra, et al.
Publicado: (2018)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

2237. Early Discontinuation of Antibacterials Is Safe for Patients with Community-Acquired Pneumonia (CAP) Who Have a Positive Viral Test, Negative Tests for Bacteria, and Low Procalcitonin
por: Politis, Paula Ann, et al.
Publicado: (2019)

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia
por: Triner, Molly, et al.
Publicado: (2019)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Reply to Huttner et al.: 2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Metlay, Joshua P., et al.
Publicado: (2020)

Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department
por: Fiumefreddo, Rico, et al.
Publicado: (2009)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

The Queensland experience of participation in a national drug use evaluation project, Community-acquired pneumonia – towards improving outcomes nationally (CAPTION)
por: Pulver, Lisa K, et al.
Publicado: (2009)

Pneumonia Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus: Vancomycin or Linezolid?
por: Tian, Ye, et al.
Publicado: (2018)

Clinical and etiological characteristics of community-acquired pneumonia at high altitudes in Tibet, China
por: Meilang, Qucuo, et al.
Publicado: (2021)

Effects of corticosteroids on severe community-acquired pneumonia: a closer look at the evidence
por: Chiang, Cho-Han, et al.
Publicado: (2023)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia
por: Stockmann, Chris, et al.
Publicado: (2018)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

Aetiological spectrum of severe community-acquired pneumonia in HIV-positive patients from Pune, India
por: Mane, Arati, et al.
Publicado: (2018)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

The role of procalcitonin in febrile patients
por: Hatipoglu, Mustafa, et al.
Publicado: (2015)

Can we recognize severe community-acquired pneumonia without pneumonia severity index? Use of modified qSOFA with procalcitonin
por: Güleç, Tolgahan, et al.
Publicado: (2023)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired pneumonia
por: Borrelli, E, et al.
Publicado: (2002)

Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia
por: Kang, Young Ae, et al.
Publicado: (2009)

Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
por: Boussekey, N., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_elkjts2v8g09kmone2sc0l989f